Updated Jul 16, 2026
Owen Adams Catherine has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $250K.
Catherine Owen Adams is associated with ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative medicines to address unmet medical needs in central nervous system disorders. Specific details about her role and contributions to the company are not widely documented.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.8K | $0.00 | |
| 2026-06-16 | AGIO | AGIOS PHARMACEUTICALS, INC. | M — Option exercise | 2.0K | $0.00 | |
| 2026-03-27 | ACAD | ACADIA PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 11.6K | $21.47 | $250K |
| 2026-03-27 | ACAD | ACADIA PHARMACEUTICALS INC | M — Option exercise [10b5-1] | 23.5K | $0.00 |
Catherine Owen Adams is associated with ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative medicines to address unmet medical needs in central nervous system disorders. Specific details about her role and contributions to the company are not widely documented.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($250K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Owen Adams Catherine profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.